<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">

PDX Models (3)

Using PDX as Surrogate Models for TME Investigation

2 minute read

Using PDX as Surrogate Models for TME Investigation

November 3, 2017

First Stable, Serially Transplantable M5 AML PDX Model Published

4 minute read

First Stable, Serially Transplantable M5 AML PDX Model Published

October 3, 2017

Blood Cancer PDX Models: Focus on Acute Myeloid Leukemia‎

4 minute read

Blood Cancer PDX Models: Focus on Acute Myeloid Leukemia‎

September 21, 2017

How Patient Derived Tumor Grafts (PDX) Accelerate Early Drug Development

2 minute read

How Patient Derived Tumor Grafts (PDX) Accelerate Early Drug Development

August 3, 2017

How to Use PDX in Immuno-Oncology Studies

2 minute read

How to Use PDX in Immuno-Oncology Studies

July 18, 2017

How to Choose Patient-Derived Xenograft (PDX) Models

2 minute read

How to Choose Patient-Derived Xenograft (PDX) Models

May 30, 2017

When to add Patient-Derived Xenografts (PDX) to Preclinical Drug Development Programs

2 minute read

When to add Patient-Derived Xenografts (PDX) to Preclinical Drug Development Programs

May 12, 2017

The Beginners Guide to Patient-Derived Xenograft (PDX) Models

3 minute read

The Beginners Guide to Patient-Derived Xenograft (PDX) Models

May 9, 2017

Patient-Derived Xenograft Population Studies: A Better Preclinical Representation of the Clinical Drug Development Process

3 minute read

Patient-Derived Xenograft Population Studies: A Better Preclinical Representation of the Clinical Drug Development Process

May 5, 2017

Large-Scale Screening Using Patient Avatars Aid Clinical Trial Design

3 minute read

Large-Scale Screening Using Patient Avatars Aid Clinical Trial Design

May 19, 2016